Globus Medical, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US3795772082
USD
85.76
0.99 (1.17%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Globus Medical, Inc.
Sotera Health Co.
Inspire Medical Systems, Inc.
Haemonetics Corp.
Masimo Corp.
Merit Medical Systems, Inc.
Envista Holdings Corp.
Natera, Inc.
Bausch + Lomb Corp.
Lantheus Holdings, Inc.
QuidelOrtho Corp.

Why is Globus Medical, Inc. ?

1
Company has a low Debt to Equity ratio (avg) at times
2
Low Debt Company with Strong Long Term Fundamental Strength
3
The company has declared Positive results for the last 3 consecutive quarters
  • OPERATING CASH FLOW(Y) Highest at USD 669.15 MM
  • NET PROFIT(Q) Highest at USD 252.97 MM
  • RAW MATERIAL COST(Y) Fallen by -16.19% (YoY)
4
With ROE of 5.54%, it has a expensive valuation with a 1.98 Price to Book Value
  • The stock is trading at a fair value compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 7.16%, its profits have risen by 69.2% ; the PEG ratio of the company is 0.5
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to Globus Medical, Inc. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Globus Medical, Inc. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Globus Medical, Inc.
20.72%
0.64
53.51%
S&P 500
18.81%
0.70
20.15%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
29.27%
EBIT Growth (5y)
27.88%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.11
Sales to Capital Employed (avg)
0.51
Tax Ratio
20.34%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
12.35%
ROE (avg)
7.98%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
23
Industry P/E
Price to Book Value
2.63
EV to EBIT
24.97
EV to EBITDA
15.46
EV to Capital Employed
2.79
EV to Sales
4.05
PEG Ratio
0.09
Dividend Yield
NA
ROCE (Latest)
11.16%
ROE (Latest)
11.41%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
No Trend
Bullish
OBV
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

21What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD 715.2 MM

NET PROFIT(HY)

Higher at USD 369.72 MM

ROCE(HY)

Highest at 10.01%

OPERATING PROFIT(Q)

Highest at USD 205.81 MM

RAW MATERIAL COST(Y)

Fallen by -22.21% (YoY

NET SALES(Q)

Highest at USD 769.05 MM

-3What is not working for the Company
CASH AND EQV(HY)

Lowest at USD 619.97 MM

Here's what is working for Globus Medical, Inc.

Net Profit
At USD 369.72 MM has Grown at 292.93%
Year on Year (YoY)
MOJO Watch
Net Profit trend is very positive

Net Profit (USD MM)

Operating Cash Flow
Highest at USD 715.2 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Operating Profit
Highest at USD 205.81 MM and Grown
In each period in the last five periods
MOJO Watch
Near term Operating Profit trend is quite positive

Operating Profit (USD MM)

Net Profit
Higher at USD 369.72 MM
than preceding 12 month period ended Sep 2025
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

Net Sales
Highest at USD 769.05 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Net Sales
At USD 769.05 MM has Grown at 17.12%
over average net sales of the previous four periods of USD 656.62 MM
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Raw Material Cost
Fallen by -22.21% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
Highest at USD 71.13 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)

Here's what is not working for Globus Medical, Inc.

Cash and Eqv
Lowest at USD 619.97 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents